Camila V Ventura1, Mauricio Maia2, Simone B Travassos3, Thayze T Martins3, Felipe Patriota3, Marcos Eugênio Nunes3, Cristiana Agra4, Virginia L Torres3, Vanessa van der Linden5, Regina C Ramos6, Maria Ângela W Rocha6, Paula S Silva6, Liana O Ventura3, Rubens Belfort2. 1. Altino Ventura Foundation, Recife, Brazil2Pernambuco's Eye Hospital (HOPE), Recife, Brazil3Department of Ophthalmology and Visual Sciences, Paulista School of Medicine, Federal University of São Paulo and Vision Institute, São Paulo, Brazil. 2. Department of Ophthalmology and Visual Sciences, Paulista School of Medicine, Federal University of São Paulo and Vision Institute, São Paulo, Brazil. 3. Altino Ventura Foundation, Recife, Brazil2Pernambuco's Eye Hospital (HOPE), Recife, Brazil. 4. Pernambuco's Eye Hospital (HOPE), Recife, Brazil. 5. Barão de Lucena Hospital, Recife, Brazil. 6. Oswaldo Cruz University Hospital, Recife, Brazil.
Abstract
IMPORTANCE: The Zika virus (ZIKV) might cause microcephaly and ophthalmoscopic findings in infants of mothers infected during pregnancy. OBJECTIVE: To assess and identify possible risk factors for ophthalmoscopic findings in infants born with microcephaly and a presumed clinical diagnosis of ZIKV intrauterine infection. DESIGN, SETTING, AND PARTICIPANTS: We conducted a cross-sectional study at the Altino Ventura Foundation in Recife, Brazil, that included 40 infants with microcephaly born in Pernambuco state, Brazil, between May and December 2015. Toxoplasmosis, rubella, cytomegalovirus, syphilis, and human immunodeficiency virus were ruled out in all of them. Testing of cerebrospinal fluid for ZIKV using IgM antibody-capture enzyme-linked immunosorbent assay was performed in 24 of 40 infants (60.0%). The infants and mothers underwent ocular examinations. The infants were divided into 2 groups, those with and without ophthalmoscopic alterations, for comparison. MAIN OUTCOMES AND MEASURES: Identification of risk factors for ophthalmoscopic findings in infants born with microcephaly and ZIKV intrauterine infection. RESULTS: Among the 40 infants, the mean (SD) age was 2.2 (1.2) months (range, 0.1-7.3 months). Of the 24 infants tested, 100% had positive results for ZIKV infection: 14 of 22 infants (63.6%) from the group with ophthalmoscopic findings and 10 of 18 infants (55.6%) from the group without ophthalmoscopic findings. The major symptoms reported in both groups were rash by 26 mothers (65.0%), fever by 9 mothers (22.5%), headache by 9 mothers (22.5%), and arthralgia by 8 mothers (20.0%). No mothers reported conjunctivitis or other ocular symptoms during pregnancy or presented signs of uveitis at the time of examination. Thirty-seven eyes (46.3%) of 22 infants (55.0%) had ophthalmoscopic alterations. Ten mothers (71.4%) of infants with ocular findings reported symptoms during the first trimester (frequency, 0.48; 95% CI, 0.02-0.67; P = .04). A difference was also observed between the groups of infants with and without ocular findings regarding the cephalic perimeter: mean (SD) of 28.8 (1.7) and 30.3 (1.5), respectively (frequency, -1.50; 95% CI, -2.56 to -0.51; P = .004). CONCLUSIONS AND RELEVANCE: Ocular involvement in infants with presumed ZIKV congenital infection were more often seen in infants with smaller cephalic diameter at birth and in infants whose mothers reported symptoms during the first trimester.
IMPORTANCE: The Zika virus (ZIKV) might cause microcephaly and ophthalmoscopic findings in infants of mothers infected during pregnancy. OBJECTIVE: To assess and identify possible risk factors for ophthalmoscopic findings in infants born with microcephaly and a presumed clinical diagnosis of ZIKV intrauterine infection. DESIGN, SETTING, AND PARTICIPANTS: We conducted a cross-sectional study at the Altino Ventura Foundation in Recife, Brazil, that included 40 infants with microcephaly born in Pernambuco state, Brazil, between May and December 2015. Toxoplasmosis, rubella, cytomegalovirus, syphilis, and human immunodeficiency virus were ruled out in all of them. Testing of cerebrospinal fluid for ZIKV using IgM antibody-capture enzyme-linked immunosorbent assay was performed in 24 of 40 infants (60.0%). The infants and mothers underwent ocular examinations. The infants were divided into 2 groups, those with and without ophthalmoscopic alterations, for comparison. MAIN OUTCOMES AND MEASURES: Identification of risk factors for ophthalmoscopic findings in infants born with microcephaly and ZIKV intrauterine infection. RESULTS: Among the 40 infants, the mean (SD) age was 2.2 (1.2) months (range, 0.1-7.3 months). Of the 24 infants tested, 100% had positive results for ZIKV infection: 14 of 22 infants (63.6%) from the group with ophthalmoscopic findings and 10 of 18 infants (55.6%) from the group without ophthalmoscopic findings. The major symptoms reported in both groups were rash by 26 mothers (65.0%), fever by 9 mothers (22.5%), headache by 9 mothers (22.5%), and arthralgia by 8 mothers (20.0%). No mothers reported conjunctivitis or other ocular symptoms during pregnancy or presented signs of uveitis at the time of examination. Thirty-seven eyes (46.3%) of 22 infants (55.0%) had ophthalmoscopic alterations. Ten mothers (71.4%) of infants with ocular findings reported symptoms during the first trimester (frequency, 0.48; 95% CI, 0.02-0.67; P = .04). A difference was also observed between the groups of infants with and without ocular findings regarding the cephalic perimeter: mean (SD) of 28.8 (1.7) and 30.3 (1.5), respectively (frequency, -1.50; 95% CI, -2.56 to -0.51; P = .004). CONCLUSIONS AND RELEVANCE: Ocular involvement in infants with presumed ZIKVcongenital infection were more often seen in infants with smaller cephalic diameter at birth and in infants whose mothers reported symptoms during the first trimester.
Authors: Victor S Santos; Sheila J G Oliveira; Ricardo Q Gurgel; Dorothy R R Lima; Cliomar A Dos Santos; Paulo R S Martins-Filho Journal: Am J Trop Med Hyg Date: 2017-07 Impact factor: 2.345
Authors: Andrea A Zin; Irena Tsui; Julia Rossetto; Zilton Vasconcelos; Kristina Adachi; Stephanie Valderramos; Umme-Aiman Halai; Marcos Vinicius da Silva Pone; Sheila Moura Pone; Joel Carlos Barros Silveira Filho; Mitsue S Aibe; Ana Carolina C da Costa; Olivia A Zin; Rubens Belfort; Patricia Brasil; Karin Nielsen-Saines; Maria Elisabeth Lopes Moreira Journal: JAMA Pediatr Date: 2017-09-01 Impact factor: 16.193
Authors: Irena Tsui; Luiza M Neves; Kristina Adachi; Stephanie L Gaw; Jose Paulo Pereira; Patricia Brasil; Karin Nielsen-Saines; Maria Elisabeth Lopes Moreira; Andrea A Zin Journal: Ophthalmic Surg Lasers Imaging Retina Date: 2019-12-01 Impact factor: 1.300
Authors: Shuang Zhu; Huanle Luo; Hua Liu; Yonju Ha; Elizabeth R Mays; Ryan E Lawrence; Evandro Winkelmann; Alan D Barrett; Sylvia B Smith; Min Wang; Tian Wang; Wenbo Zhang Journal: Antiviral Res Date: 2017-07-21 Impact factor: 5.970
Authors: Cynthia A Moore; J Erin Staples; William B Dobyns; André Pessoa; Camila V Ventura; Eduardo Borges da Fonseca; Erlane Marques Ribeiro; Liana O Ventura; Norberto Nogueira Neto; J Fernando Arena; Sonja A Rasmussen Journal: JAMA Pediatr Date: 2017-03-01 Impact factor: 16.193
Authors: Jonathan J Miner; Abdoulaye Sene; Justin M Richner; Amber M Smith; Andrea Santeford; Norimitsu Ban; James Weger-Lucarelli; Francesca Manzella; Claudia Rückert; Jennifer Govero; Kevin K Noguchi; Gregory D Ebel; Michael S Diamond; Rajendra S Apte Journal: Cell Rep Date: 2016-09-06 Impact factor: 9.423